TABLE 1

Description of CYP2C19 variants examined in this study

VariantscDNA ChangeLocationAmino Acid ChangeAllele No. or dbSNP Identification No.Allele Frequencya
WhitesBlacksAsians
CYP2C19.1ANoneNoneCYP2C19*1A
CYP2C19.1B99C>T, 991A>GExon7I331VCYP2C19*1BN.R.N.R.0.6–0.955 (1,2)
CYP2C19.5B99C>T, 991A>G, 1297C>TExon9I331V, R433WCYP2C19*5B0 (3)N.R.0–0.001 (3)
CYP2C19.699C>T, 395G>A, 991A>GExon3R132Q, I331VCYP2C19*60–0.003 (4)N.R.N.R.
CYP2C19.899C>T, 358T>CExon3W120RCYP2C19*80–0.007 (5)N.R.N.R.
CYP2C19.9991A>GExon3R144H, I331VCYP2C19*90–0.0029 (6–8)0.04–0.06 (6,7)0 (6,7)
CYP2C19.1099C>T, 680C>T, 991A>GExon5P227L, I331VCYP2C19*100 (6,8)0.02 (6)0 (6)
CYP2C19.1199C>T, 449G>A, 991A>GExon3R150H, I331VCYP2C19*110–0.03 (6,8)0 (6)0 (6)
CYP2C19.1399C>T, 991A>G, 1228C>TExon8I331V, R410CCYP2C19*130 (6,8)0.02 (6)0 (6)
CYP2C19.1496C>T, 99C>T, 991A>GExon1L17P, I331VCYP2C19*140 (6)0.02 (6)0 (6)
CYP2C19.1555A>C, 99C>TExon1I19LCYP2C19*150 (6)0.02 (6)0 (6)
CYP2C19.1699C>T, 1324C>TExon9R442CCYP2C19*16N.R.N.R.0–0.017 (9)
CYP2C19.1899C>T, 986G>A;Exon7R329HCYP2C19*18N.R.N.R.0.002 (1)
CYP2C19.1999C>T, 151A>G;Exon1S51GCYP2C19*19N.R.N.R.0.002 (1)
E92D99C>T, 276G>C, 991A>GExon2E92D, I331VCYP2C19*2B0.02–0.0047 (6,8)0 (6)0 (6)
A161P99C>T, 481G>C, 991A>G,Exon3A161P, I331VCYP2C19*2CN.R.N.R.0.006 (1)
D360N99C>T, 991A>G, 1078G>AExon7D360N, I331VCYP2C19*3BN.R.N.R.0.002–0.02 (1,2)
M74T221T>CExon2M74Trs283995050 (7)0 (7)0.05 (7)
F168L502T>CExon4F168Lrs283995100.02 (7)0 (7)0 (7)
E122A356A>CExon3E122Ars178851790.006 (mixed population in North America) (10)
W212C636G>TExon4W212Crs4986893
  • N.R., not reported.

  • a The allele frequencies are from the following references: 1, Fukushima-Uesaka et al. (2005); 2, Zhou et al. (2009); 3, Ibeanu et al. (1998a); 4, Ibeanu et al. (1998b); 5, Ibeanu et al. (1999); 6, Blaisdell et al. (2002); 7, Solus et al. (2004); 8, Nakamoto et al. (2007); 9, Morita et al. (2004); and 10, http://www.ncbi.nlm.nih.gov/snp/.